Showing posts with label medicine. Show all posts
Showing posts with label medicine. Show all posts

Friday, July 29, 2016

No dream: Electric brain stimulation during sleep can boost memory


When you sleep, your brain is busy storing and consolidating things you learned that day, stuff you'll need in your memory toolkit tomorrow, next week, or next year. For many people, especially those with neurological conditions, memory impairment can be a debilitating symptom that affects every-day life in profound ways. For the first time, UNC School of Medicine scientists report using transcranial alternating current stimulation, or tACS, to target a specific kind of brain activity during sleep and strengthen memory in healthy people.
The findings, published in the journal Current Biology, offer a non-invasive method to potentially help millions of people with conditions such as autism, Alzheimer's disease, schizophrenia, and major depressive disorder.
For years, researchers have recorded electrical brain activity that oscillates or alternates during sleep; they present as waves on an electroencephalogram (EEG). These waves are called sleep spindles, and scientists have suspected their involvement in cataloging and storing memories as we sleep.
"But we didn't know if sleep spindles enable or even cause memories to be stored and consolidated," said senior author Flavio Frohlich, PhD, assistant professor of psychiatry and member of the UNC Neuroscience Center. "They could've been merely byproducts of other brain processes that enabled what we learn to be stored as a memory. But our study shows that, indeed, the spindles are crucial for the process of creating memories we need for every-day life. And we can target them to enhance memory."
This marks the first time a research group has reported selectively targeting sleep spindles without also increasing other natural electrical brain activity during sleep. This has never been accomplished with tDCS -- transcranial direct current stimulation -- the much more popular cousin of tACS in which a constant stream of weak electrical current is applied to the scalp.
During Frohlich's study, 16 male participants underwent a screening night of sleep before completing two nights of sleep for the study.
Before going to sleep each night, all participants performed two common memory exercises -- associative word-pairing tests and motor sequence tapping tasks, which involved repeatedly finger-tapping a specific sequence. During both study nights, each participant had electrodes placed at specific spots on their scalps. During sleep one of the nights, each person received tACS -- an alternating current of weak electricity synchronized with the brain's natural sleep spindles. During sleep the other night, each person received sham stimulation as placebo.
Each morning, researchers had participants perform the same standard memory tests. Frohlich's team found no improvement in test scores for associative word-pairing but a significant improvement in the motor tasks when comparing the results between the stimulation and placebo night.
"This demonstrated a direct causal link between the electric activity pattern of sleep spindles and the process of motor memory consolidation." Frohlich said.
Caroline Lustenberger, PhD, first author and postdoctoral fellow in the Frohlich lab, said, "We're excited about this because we know sleep spindles, along with memory formation, are impaired in a number of disorders, such as schizophrenia and Alzheimer's. We hope that targeting these sleep spindles could be a new type of treatment for memory impairment and cognitive deficits."
Frohlich said, "The next step is to try the same intervention, the same type of non-invasive brain stimulation, in patients that have known deficits in these spindle activity patterns."
Frohlich's team previously used tACS to target the brain's natural alpha oscillations to boost creativity. This was a proof of concept. It showed it was possible to target these particular brain waves, which are prominent as we create ideas, daydream, or meditate. These waves are impaired in people with neurological and psychiatric illnesses, including depression.

Story Source:
The above post is reprinted from materials provided by University of North Carolina Health Care. Note: Materials may be edited for content and length.

Wednesday, July 27, 2016

DNA analyses reveal genetic identities of world's first farmers


Conducting the first large-scale, genome-wide analyses of ancient human remains from the Near East, an international team led by Harvard Medical School has illuminated the genetic identities and population dynamics of the world's first farmers.
The study reveals three genetically distinct farming populations living in the Near East at the dawn of agriculture 12,000 to 8,000 years ago: two newly described groups in Iran and the Levant and a previously reported group in Anatolia, in what is now Turkey.
The findings, published in Nature on July 25, also suggest that agriculture spread in the Near East at least in part because existing groups invented or adopted farming technologies, rather than because one population replaced another.
"Some of the earliest farming was practiced in the Levant, including Israel and Jordan, and in the Zagros mountains of Iran--two edges of the Fertile Crescent," said Ron Pinhasi, associate professor of archaeology at University College Dublin and co-senior author of the study. "We wanted to find out whether these early farmers were genetically similar to one another or to the hunter-gatherers who lived there before so we could learn more about how the world's first agricultural transition occurred."
The team's analyses alter what is known about the genetic heritage of present-day people in western Eurasia. They now appear to have descended from four major groups: hunter-gatherers in what is now western Europe, hunter-gatherers in eastern Europe and the Russian steppe, the Iran farming group and the Levant farming group.
"We found that the relatively homogeneous population seen across western Eurasia today, including Europe and the Near East, used to be a highly substructured collection of people who were as different from one another as present-day Europeans are from East Asians," said David Reich, professor of genetics at Harvard Medical School and co-senior author of the study.
"Near East populations mixed with one another over time and migrated into surrounding regions to mix with the people living there until those initially quite diverse groups became genetically very similar," added Iosif Lazaridis, HMS research fellow in genetics and first author of the study.
Early adopters
Even as advances in ancient-DNA technology have made it possible to probe population mixing and large-scale migrations that occurred thousands of years ago, researchers have had trouble studying the genetic history of the Near East because the region's warm climate has degraded much of the DNA in unearthed bones.
The team overcame the problem of poor-quality DNA in part by extracting genetic material from ear bones that can yield up to 100 times more DNA than other bones in the body. The team also used a technique called in-solution hybridization to enrich for human DNA and filter out contaminant DNA from microbes.
The combined techniques allowed the researchers to gather high quality genomic information from 44 ancient Near Easterners who lived between 14,000 and 3,400 years ago: hunter-gatherers from before the invention of farming, the first farmers themselves and their successors.
By comparing the genomes to one another as well as to those of nearly 240 previously studied ancient people from nearby regions and about 2,600 present-day people, the researchers learned that the first farming cultures in the Levant, Iran and Anatolia were all genetically distinct. Farmers in the Levant and Iran were genetically similar, however, to earlier hunter-gatherers who had lived in the same areas.
"Maybe one group domesticated goats and another began growing wheat, and the practices were shared in some way," said Lazaridis. "These different populations all invented or adopted some facets of the farming revolution, and they all flourished."
The findings tell a different story from what researchers believe happened later in Europe, when the first farmers moved in from Anatolia and largely replaced the hunter-gatherer populations who'd been living there.
Mix and match
Over the following 5,000 years, the Near East farming groups mixed with one another and with hunter-gatherers in Europe.
"All this extraordinary diversity collapsed," said Reich. "By the Bronze Age, populations had ancestry from many sources and broadly resembled present-day ones."
The researchers also learned how descendants of each early farming group, even as they began to intermingle, contributed to the genetic ancestry of people in different parts of the world: Farmers related to the Anatolian group spread west into Europe, people related to the Levant group moved south into East Africa, people related to those in Iran or the Caucasus went north into the Russian steppe, and people related to both the farmers in Iran and hunter-gatherers from the steppe spread into South Asia.
"The Near East was the missing link to understanding many human migrations," said Pinhasi.
Finally, the study provides a few more clues about a hypothetical, even more ancient, population called the Basal Eurasians, an early diverging branch of the family tree of humans living outside Africa, whose existence Lazaridis has inferred from DNA analyses but whose physical remains have not yet been found.
"Every single group from the ancient Near East appears to have Basal Eurasian ancestry--up to around fifty percent in the earliest groups," said Lazaridis.
To the researchers' surprise, statistical analyses suggested that the Basal Eurasians may have had no Neanderthal DNA. Other non-African groups have at least 2 percent Neanderthal DNA.
The team believes this finding could help explain why West Eurasians have less Neanderthal DNA than East Asians, even though Neanderthals are known to have lived in west Eurasia.
"Admixture with Basal Eurasians may have diluted the Neanderthal ancestry in West Eurasians who have ancient Near Eastern farmer ancestry," said Reich. "Basal Eurasians may have lived in parts of the Near East that did not come into contact with the Neanderthals."
Going forward, said Pinhasi, "We're eager to study remains from the world's first civilizations, who succeeded the samples analyzed in the study. The people everyone reads about in history books are now within the reach of our genetic technology."

Story Source:
The above post is reprinted from materials provided by Harvard Medical School. Note: Materials may be edited for content and length.

Monday, July 25, 2016

New detector at South Pole shows early success at neutrino hunting


In the second it takes to read these words, 65 billion neutrinos will shoot through every square centimeter of your body. Luckily, these infinitesimal particles don't do any harm -- they pass through us, as they do with most everything, without stopping or interacting.
"Partly because it's so tiny, a neutrino has this unique property -- it's able to penetrate through matter very easily," said David Besson, professor of physics and astronomy at the University of Kansas. "A neutrino produced in the center of the Sun can typically require a light year's worth of solid lead to stop that neutrino, whereas light, in the form of photons from the Sun, you can block out easily with dark sunglasses."
According to Besson, the ability of neutrinos to pierce through anything and keep on moving makes them ideal cosmic messengers.
"The fact that neutrinos are so penetrating makes them interesting to astrophysicists," he said. "Huge and cataclysmic stellar explosions that we'd like to understand produce lots of particles, but most of them will be absorbed by material in the interstellar medium before getting to our observatories. But neutrinos, because they're so penetrating, can carry info from much farther away -- much more than a photon, for example."
Yet, neutrinos are tricky to detect precisely because they don't interact with matter.
Today, Besson is part of a multinational research effort at the South Pole to build and operate the Askaryan Radio Array, a large-scale radio-detection instrument that will identify radio waves cast off from high-energy neutrinos far underneath the Antarctic ice shelf. Eventually the array will be composed of 37 antennae stations that effectively will transform hundreds of cubic kilometers into a colossal neutrino detector.


The ARA team recently published a performance review of the first two stations to come online in the peer-reviewed publication Physical Review D.Their findings showed great potential for the detector to push forward understanding of the cosmos once it's fully operational.
"The first two stations are showing a lot of promise of detecting neutrinos," Besson said. "Radio transparency within the ice is very high. We measured at this at the South Pole and were able to send radio waves through about 4 miles' worth of ice. So that's pretty transparent, and it means you can bury an antenna in the Antarctic ice and scan for several kilometers around for potential neutrino interactions."
Besson performs data analysis and serves as a spokesman for the ARA group. He said once the array is fully operational, it could produce information from neutrinos that would shed light on the state of the current universe and also the universe's origins.
"Neutrinos tell us something about cataclysmic explosions that happen today or within the recent history of the universe," he said. "But also, because they can reach us from very farthest periphery of the distant universe, they carry an imprint of processes that occurred in early universe. If you can accumulate enough data from them, you can test theories of evolution of the cosmos."
While scientists are learning secrets of the universe, KU undergraduate and graduate students will have the opportunity to learn about neutrinos and neutrino detection via the array. Moreover, two of the graduate students will travel to Antarctica to engage in research this October. Their route will take them from Lawrence to Kansas City, Los Angeles, New Zealand, McMurdo Station in Antarctica, and finally to the South Pole aboard a C-130 military jet.
"There's a particle astrophysics group here at KU -- they work on radio-wave detection of cosmic rays," Besson said. That group includes four graduate students and three undergraduates.
Further, Besson is working with high school students at KU this summer, including soon-to-be Jayhawks.
"Two of them are coming here as undergrads in the fall," he said. "The nice thing about radio waves, unlike gamma rays or x-rays, is they're familiar to people, and the equipment you need to send and receive radio waves are just antennas, and it doesn't take much work to get to point where you can design and build and test your own antennae."

Story Source:
The above post is reprinted from materials provided by University of Kansas. Note: Materials may be edited for content and length.

Sunday, July 24, 2016

A new key to understanding molecular evolution in space


Scientists at Hokkaido University have revealed temperature-dependent energy-state conversion of molecular hydrogen on ice surfaces, suggesting the need for a reconsideration of molecular evolution theory.
Molecular hydrogen, the most abundant element in space, is created when two hydrogen atoms bond on minute floating ice particles. It has two energy states: ortho and para, depending on the direction of proton spins. Ortho-hydrogen converts to para-hydrogen on extremely low temperature ice particles, though its mechanism remained unclear.
When molecular hydrogen is released from tiny ice particles in space, the particular state of its energy plays a key role in molecular evolution -- the process of generating a wide range of molecules over a long period of time in space.
In the study, the researchers developed a special system that could detect the ortho/para ratio of molecular hydrogen on artificial ice particles. The study discovered that the ratio of the ortho-to-para conversion rate (as time passed) was dramatically different in the relatively small temperature range of between -264C and -257C, thus, in a world first, unraveling the conversion mechanism. Ortho-hydrogen converts to para-hydrogen by releasing energy to the ice, in a temperature dependent manner.

Until now, the energy conversion rate was believed to be identical regardless of the temperature of ice particles -- a theory that has been scotched by the new research. The finding will likely prompt scientists to rebuild theories of molecular evolution, opening new horizons in studies of molecular formation and molecular evolution.

Story Source:
The above post is reprinted from materials provided by Hokkaido University. Note: Materials may be edited for content and length.

Common colon cancer tumor type blocked in mice: Clinical trial August 2016


A new scientific study has identified why colorectal cancer cells depend on a specific nutrient, and a way to starve them of it. Over one million men and women are living with colorectal cancer in the United States. The National Cancer Institute estimates 4.5% of all men and women will be diagnosed with the cancer during their lifetime, making it the third most common non-skin cancer.
In the study published online in Nature Communications, researchers showed how certain colorectal cancer cells reprogram their metabolism using glutamine, a non-essential amino acid. Many cancer cells rely on glutamine to survive. How they become so dependent on the molecule is hotly debated in the field.
Researchers studied a subset of colorectal cancer cells containing a genetic mutation called PIK3CA. This mutation is located in a gene critical for cell division and movement, and is found in approximately one third of all colorectal cancers. The mutation is also the most commonly identified genetic mutation across all cancers, making the results of the study universally appealing.
Researchers were interested in determining whether or not the common PIK3CA mutation contributes to changes in cancer cell metabolism, such as how nutrients like glutamine are processed. Normally, glutamine is broken down by cancer cells into several other molecules with the help of specific enzymes. This complicated system helps produce adenosine triphosphate, the energy currency of all cells, and other molecules critical for colorectal cancer cell growth.
The researchers found that colorectal cells with the PIK3CA mutation broke down significantly more glutamine than cells without the mutation. The researchers identified several enzymes involved in the process that are more active in the mutant cancer cells than in other cell types, explaining the increased need for glutamine. These enzymes become overactive in the mutant cancer cells due to a cascade of signals led by the protein encoded by mutant PIK3CA gene. This finding represents a novel and important link between the common PIK3CA mutation and altered glutamine metabolism in cancer cells.
Zhenghe John Wang, PhD, professor of genetics and genome sciences and co-leader of the Cancer Genetics Program at Case Western Reserve University School of Medicine helped lead the study. "In layman's terms, we discovered that colon cancers with PIK3CA oncogenic mutations are addicted to glutamine, a particular nutrient for cancer cells. We also demonstrated that these cancers can be starved to death by depriving glutamine with drugs."
When the researchers lowered the amount of glutamine available to mutant cancer cells growing in laboratory dishes, the cancer cells died. This discovery led the team to investigate the effects of blocking glutamine availability in mice with colorectal cancer tumors containing the common PIK3CA mutation. Wang and colleagues found that exposing these mice to a compound that blocks glutamine metabolism consistently suppressed tumor growth. They did not observe the same effect on tumors without the mutation. Together, these results provide a promising new therapeutic avenue to suppress growth of colorectal tumors with the PIK3CA mutation. The researchers have filed a patent application based on the unique mechanism of tumor suppression they have identified and the work is available for licensing.
"This study provides the basis for a colon cancer treatment clinical trial that will be started in the summer at the University Hospitals Seidman Cancer Center," according to Neal Meropol, MD, Dr. Lester E. Coleman, Jr. Professor of Cancer Research and Therapeutics, chief of the division of hematology and oncology, and principal investigator for the trial. The phase I/II study will test the effects of a glutamine metabolism inhibitor in patients with advanced colorectal tumors.

Story Source:
The above post is reprinted from materials provided by Case Western Reserve University. Note: Materials may be edited for content and length.

Surface tension can sort droplets for biomedical applications


Imagine being able to instantly diagnose diabetes, Ebola or some other disease, simply by watching how a droplet of blood moves on a surface.
That's just one potential impact of new research led by Arun Kota, assistant professor in Colorado State University's Department of Mechanical Engineering and the School of Biomedical Engineering. Kota's lab makes coatings that repel not just water, but virtually any liquid, including oils and acids -- a property called superomniphobicity.
They described their most recent innovation in engineered superomniphobic surfaces in Lab on a Chip, a publication of the Royal Society of Chemistry. Kota and his team engineered a simple and inexpensive device that can sort droplets of liquid based solely on the liquids' varying surface tensions. They did it by making their device's surface tunable, meaning they can manipulate its surface chemistry to turn up or turn down how well it repels liquids.
The researchers patterned a surface with titanium dioxide "nanoflowers" by decorating a pristine thin film of titanium in a nanoscale pattern that looks like a field of flowers under a scanning electron microscope. Exploiting titanium dioxide's photocatalytic properties, they slightly changed the surface chemistry on various spots on the device by shining UV light on it for set lengths of time.
The result: a flat film that can sort liquid droplets based on their surface tensions, when the device is placed at a slight incline.
This elegantly simple concept could form the basis for a host of applications, from biosensors for point-of-care diagnostic platforms to lab-on-chip systems that can quickly distinguish between droplets of different chemicals, or diseased and non-diseased blood.
Fundamentally, Kota's team is interested in the physics and chemistry of how and why some materials result in superomniphobicity, as well as perfecting the science behind superomniphobic surfaces.
"But we're engineers, so we need applications that can translate commercially," Kota said. "The dream is to create superomniphobic surfaces that are mechanically durable. People can make interesting surfaces, but the problem is that some aren't very durable. If you can make something but it doesn't last, who cares?"

Story Source:
The above post is reprinted from materials provided by Colorado State University. Note: Materials may be edited for content and length.

Antibiotics weaken Alzheimer's disease progression through changes in the gut microbiome


Long-term treatment with broad spectrum antibiotics decreased levels of amyloid plaques, a hallmark of Alzheimer's disease, and activated inflammatory microglial cells in the brains of mice in a new study by neuroscientists from the University of Chicago.
The study, published July 21, 2016, in Scientific Reports, also showed significant changes in the gut microbiome after antibiotic treatment, suggesting the composition and diversity of bacteria in the gut play an important role in regulating immune system activity that impacts progression of Alzheimer's disease.
"We're exploring very new territory in how the gut influences brain health," said Sangram Sisodia, PhD, Thomas Reynolds Sr. Family Professor of Neurosciences at the University of Chicago and senior author of the study. "This is an area that people who work with neurodegenerative diseases are going to be increasingly interested in, because it could have an influence down the road on treatments."
Two of the key features of Alzheimer's disease are the development of amyloidosis, accumulation of amyloid-ß (Aß) peptides in the brain, and inflammation of the microglia, brain cells that perform immune system functions in the central nervous system. Buildup of Aß into plaques plays a central role in the onset of Alzheimer's, while the severity of neuro-inflammation is believed to influence the rate of cognitive decline from the disease.
For this study, Sisodia and his team administered high doses of broad-spectrum antibiotics to mice over five to six months. At the end of this period, genetic analysis of gut bacteria from the antibiotic-treated mice showed that while the total mass of microbes present was roughly the same as in controls, the diversity of the community changed dramatically. The antibiotic-treated mice also showed more than a two-fold decrease in Aß plaques compared to controls, and a significant elevation in the inflammatory state of microglia in the brain. Levels of important signaling chemicals circulating in the blood were also elevated in the treated mice.
While the mechanisms linking these changes is unclear, the study points to the potential in further research on the gut microbiome's influence on the brain and nervous system.

"We don't propose that a long-term course of antibiotics is going to be a treatment -- that's just absurd for a whole number of reasons," said Myles Minter, PhD, a postdoctoral scholar in the Department of Neurobiology at UChicago and lead author of the study. "But what this study does is allow us to explore further, now that we're clearly changing the gut microbial population and have new bugs that are more prevalent in mice with altered amyloid deposition after antibiotics."
The study is the result of one the first collaborations from the Microbiome Center, a joint effort by the University of Chicago, the Marine Biological Laboratory and Argonne National Laboratory to support scientists at all three institutions who are developing new applications and tools to understand and harness the capabilities of microbial systems across different fields. Sisodia, Minter and their team worked with Eugene B. Chang, Martin Boyer Professor of Medicine at UChicago, and Vanessa Leone, PhD, a postdoctoral scholar in Chang's lab, to analyze the gut microbes of the mice in this study.
Minter said the collaboration was enabling, and highlighted the cross-disciplinary thinking necessary to tackle a seemingly intractable disease like Alzheimer's. "Once you put ideas together from different fields that have largely long been believed to be segregated from one another, the possibilities are really amazing," he said.
Sisodia cautioned that while the current study opens new possibilities for understanding the role of the gut microbiome in Alzheimer's disease, it's just a beginning step.
"There's probably not going to be a cure for Alzheimer's disease for several generations, because we know there are changes occurring in the brain and central nervous system 15 to 20 years before clinical onset," he said. "We have to find ways to intervene when a patient starts showing clinical signs, and if we learn how changes in gut bacteria affect onset or progression, or how the molecules they produce interact with the nervous system, we could use that to create a new kind of personalized medicine."

Story Source:
The above post is reprinted from materials provided by University of Chicago Medical Center. Note: Materials may be edited for content and length.

Background noise may hinder toddlers' ability to learn words

The environments children are in, including how much and what kinds of stimulation they are exposed to, influence what and how they learn. One important task for children is zeroing in on the information that's relevant to what they're learning and ignoring what isn't. A new study has found that the presence of background noise in the home or at school makes it more difficult for toddlers to learn new words. The study also found that providing additional language cues may help young children overcome the effects of noisy environments.
Conducted at the University of Wisconsin-Madison, the research appears in the journal Child Development.
"Learning words is an important skill that provides a foundation for children's ability to achieve academically," notes Brianna McMillan, doctoral student in psychology at the University of Wisconsin-Madison, who led the study.
"Modern homes are filled with noisy distractions such as TV, radio, and people talking that could affect how children learn words at early ages. Our study suggests that adults should be aware of the amount of background speech in the environment when they're interacting with young children."
Studies on the impact of environmental noise suggest that too much noise can affect children both cognitively and psycho-physiologically, as seen in more negative school performance and increased levels of cortisol and heart rate. However, most studies of word learning are conducted in quiet laboratory settings. This study focused on word learning but attempted to replicate the noisy environments children may inhabit at home and at school. In the study, 106 children ages 22 to 30 months took part in three experiments in which they were taught names for unfamiliar objects and then tested on their ability to recognize the objects when they were labeled. First, toddlers listened to sentences featuring two new words.
Then they were taught which objects the new names corresponded to. Finally, the toddlers were tested on their ability to recall the words.
In the first experiment, 40 toddlers (ages 22 to 24 months) heard either louder or quieter background speech when learning the new words. Only toddlers who were exposed to the quieter background speech successfully learned the words. In the second experiment, a different group of 40 toddlers (ages 28 to 30 months) was tested to determine whether somewhat older children could better overcome the effects of background noise. Again, only when background noise was quieter could the older toddlers successfully learn the new words.
In the third experiment, 26 older toddlers were first exposed to two word labels in a quiet environment. Next, the toddlers were taught the meanings of four word labels -- two they had just heard and two new ones. Toddlers were taught the meanings of all these labels in the same noisy environment that impaired learning in the second experiment. The children learned the new words and their meanings only when they had first heard the labels in a quiet environment, suggesting that experience with the sounds of the words without distracting background noise helps children subsequently map those sounds to meaning.
In sum, the study shows that while louder background speech hindered toddlers' ability to learn words, cues in the environment helped them overcome this difficulty. "Hearing new words in fluent speech without a lot of background noise before trying to learn what objects the new words corresponded to may help very young children master new vocabulary," suggests Jenny Saffran, College of Letters & Science Professor of Psychology at the University of Wisconsin-Madison, who coauthored the study. "But when the environment is noisy, drawing young children's attention to the sounds of the new word may help them compensate."
Children will rarely be in a completely quiet environment when learning. Parents and teachers may find that reducing background noise or highlighting important information can help children learn even when there is background noise. These suggestions may be especially important for low-income households because research shows that such homes on average have higher noise levels due to urban settings and crowding.

Story Source:
The above post is reprinted from materials provided by Society for Research in Child Development. Note: Materials may be edited for content and length.

Friday, February 12, 2016

2015 Nobel Prize in Physiology or Medicine

The Nobel Assembly at Karolinska Institutet has decided to award the 2015 Nobel Prize in Physiology or Medicine with one half jointly to William C. Campbell and Satoshi Ōmura for their discoveries concerning a novel therapy against infections caused by roundworm parasites and the other half to Youyou Tu for her discoveries concerning a novel therapy against malaria.
Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world''s poorest populations and represent a huge barrier to improving human health and wellbeing. This year''s Nobel Laureates have developed therapies that have revolutionized the treatment of some of the most devastating parasitic diseases.
William C. Campbell and Satoshi Ōmura discovered a new drug, Avermectin, the derivatives of which have radically lowered the incidence of River Blindness and Lymphatic Filariasis, as well as showing efficacy against an expanding number of other parasitic diseases. Youyou Tu discovered Artemisinin, a drug that has significantly reduced the mortality rates for patients suffering from Malaria.
These two discoveries have provided humankind with powerful new means to combat these debilitating diseases that affect hundreds of millions of people annually. The consequences in terms of improved human health and reduced suffering are immeasurable.
Parasites cause devastating diseases
We live in a biologically complex world, which is populated not only by humans and other large animals, but also by a plethora of other organisms, some of which are harmful or deadly to us.
A variety of parasites cause disease. A medically important group are the parasitic worms (helminths), which are estimated to afflict one third of the world''s population and are particularly prevalent in sub-Saharan Africa, South Asia and Central and South America. River Blindness and Lymphatic Filariasis are two diseases caused by parasitic worms. As the name implies, River Blindness (Onchocerciasis) ultimately leads to blindness, because of chronic inflammation in the cornea. Lymphatic Filariasis, afflicting more than 100 million people, causes chronic swelling and leads to life-long stigmatizing and disabling clinical symptoms, including Elephantiasis (Lymphedema) and Scrotal Hydrocele.
Malaria has been with humankind for as long as we know. It is a mosquito-borne disease caused by single-cell parasites, which invade red blood cells, causing fever, and in severe cases brain damage and death. More than 3.4 billion of the world''s most vulnerable citizens are at risk of contracting Malaria, and each year it claims more than 450,000 lives, predominantly among children.
From bacteria and plants to novel anti-parasite therapies
After decades of limited progress in developing durable therapies for parasitic diseases, the discoveries by this year''s Laureates radically changed the situation.
Satoshi Ōmura, a Japanese microbiologist and expert in isolating natural products, focused on a group of bacteria, Streptomyces, which lives in the soil and was known to produce a plethora of agents with antibacterial activities (including Streptomycin discovered by Selman Waksman, Nobel Prize 1952). Equipped with extraordinary skills in developing unique methods for large-scale culturing and characterization of these bacteria, Ōmura isolated new strains of Streptomyces from soil samples and successfully cultured them in the laboratory. From many thousand different cultures, he selected about 50 of the most promising, with the intent that they would be further analyzed for their activity against harmful microorganisms.
William C. Campbell, an expert in parasite biology working in the USA, acquired Ōmura''s Streptomyces cultures and explored their efficacy. Campbell showed that a component from one of the cultures was remarkably efficient against parasites in domestic and farm animals. The bioactive agent was purified and named Avermectin, which was subsequently chemically modified to a more effective compound called Ivermectin. Ivermectin was later tested in humans with parasitic infections and effectively killed parasite larvae (microfilaria). Collectively, Ōmura and Campbell''s contributions led to the discovery of a new class of drugs with extraordinary efficacy against parasitic diseases.
Malaria was traditionally treated by chloroquine or quinine, but with declining success. By the late 1960s, efforts to eradicate Malaria had failed and the disease was on the rise. At that time, Youyou Tu in China turned to traditional herbal medicine to tackle the challenge of developing novel Malaria therapies. From a large-scale screen of herbal remedies in Malaria-infected animals, an extract from the plant Artemisia annua emerged as an interesting candidate. However, the results were inconsistent, so Tu revisited the ancient literature and discovered clues that guided her in her quest to successfully extract the active component from Artemisia annua. Tu was the first to show that this component, later called Artemisinin, was highly effective against the Malaria parasite, both in infected animals and in humans. Artemisinin represents a new class of antimalarial agents that rapidly kill the Malaria parasites at an early stage of their development, which explains its unprecedented potency in the treatment of severe Malaria.
Avermectin, Artemisinin and global health
The discoveries of Avermectin and Artemisinin have fundamentally changed the treatment of parasitic diseases. Today the Avermectin-derivative Ivermectin is used in all parts of the world that are plagued by parasitic diseases. Ivermectin is highly effective against a range of parasites, has limited side effects and is freely available across the globe. The importance of Ivermectin for improving the health and wellbeing of millions of individuals with River Blindness and Lymphatic Filariasis, primarily in the poorest regions of the world, is immeasurable. Treatment is so successful that these diseases are on the verge of eradication, which would be a major feat in the medical history of humankind. Malaria infects close to 200 million individuals yearly. Artemisinin is used in all Malaria-ridden parts of the world. When used in combination therapy, it is estimated to reduce mortality from Malaria by more than 20% overall and by more than 30% in children. For Africa alone, this means that more than 100,000 lives are saved each year.
The discoveries of Avermectin and Artemisinin have revolutionized therapy for patients suffering from devastating parasitic diseases. Campbell, Ōmura and Tu have transformed the treatment of parasitic diseases. The global impact of their discoveries and the resulting benefit to humankind are immeasurable.

William C. Campbell was born in 1930 in Ramelton, Ireland. After receiving a BA from Trinity College, University of Dublin, Ireland in 1952, he received a PhD from University of Wisconsin, Madison, WI, USA in 1957. From 1957-1990 he was with the Merck Institute for Therapeutic Research, from 1984-1990 as Senior Scientist and Director for Assay Research and Development. Campbell is currently a Research Fellow Emeritus at Drew University, Madison, New Jersey, USA.
Satoshi Ōmurawas born in 1935 in the Yamanashi Prefecture, Japan and is a Japanese Citizen. He received a PhD in Pharmaceutical Sciences in 1968 from University of Tokyo, Japan and a PhD in Chemistry in 1970 from Tokyo University of Science. He was a researcher at the Kitasato Institute, Japan from 1965-1971 and Professor at Kitasato University, Japan from 1975-2007. From 2007, Satoshi Ōmura has been Professor Emeritus at Kitasato University.
Youyou Tu was born in 1930 in China and is a Chinese citizen. She graduated from the Pharmacy Department at Beijing Medical University in 1955. From 1965-1978 she was Assistant Professor at the China Academy of Traditional Chinese Medicine, from 1979-1984 Associate Professor and from 1985 Professor at the same Institute. From 2000, Tu has been Chief Professor at the China Academy of Traditional Chinese Medicine.

Wednesday, February 3, 2016

This Device that bring heart back to Life!? (VIDEO)

Heart in a Box

This device can bring dead hearts back to life.

Posted by Hashem Al-Ghaili on Saturday, January 30, 2016

Monday, February 1, 2016

Hydra can modify its genetic program


Champion of regeneration, the freshwater polyp Hydra is capable of reforming a complete individual from any fragment of its body. It is even able to remain alive when all its neurons have disappeared. Researcher the University of Geneva (UNIGE), Switzerland, have discovered how: cells of the epithelial type modify their genetic program by overexpressing a series of genes, among which some are involved in diverse nervous functions.

Insufficient evidence for the use of omega 3 supplements in treating depression


New research out today concludes that there is insufficient evidence for the use of taking an Omega 3 fatty acid supplement in treating major depressive disorder.

Sunday, January 31, 2016

From what compromised memory?


Claiming that memory is very tricky specialists emphasize that it represents the miracle of human biology.

Bangladesh: L'«homme-arbre» va bientôt être opéré

MEDECINE Le jeune homme est atteint d’une maladie génétique rarissime qui entraîne le développement d’excroissances impressionnantes…

Apple fruit and its benefits

The fruit of the apple because of irreplaceable material that contains a positive effect in the treatment of many diseases.

Ad Inside Post

Comments system

Disqus Shortname